Improving Focus: Behavioral Tools & Medication for ADHD
Summary
Dr. John Kruse, a psychiatrist and circadian biology researcher specializing in ADHD, explains the full spectrum of ADHD treatments—from behavioral foundations like sleep timing, meal scheduling, and exercise to stimulant and non-stimulant medications. He offers a nuanced view of ADHD as both a biological and environmental condition, arguing that factors like circadian rhythm misalignment and lack of external structure may underlie many attention deficits. The discussion covers the relative efficacy and risks of major ADHD medications with a level of clinical detail rarely shared publicly.
Key Takeaways
- ADHD is not a deficit of attention—it’s a deficit of control over attention, including directing, sustaining, and disengaging from focus.
- Heritability of ADHD is ~0.8, roughly equivalent to height or schizophrenia, making it one of the most heritable psychiatric conditions.
- Night owl chronotype is strongly over-represented in ADHD and is genetically linked; forcing a “normal” sleep schedule may be counterproductive if an alternate schedule can be kept consistently.
- The four behavioral foundations to address before medication: sleep (especially timing), regular meals, movement/exercise, and dedicated relaxation time.
- Amphetamine-based medications (Adderall, Vyvanse) are significantly more efficacious than methylphenidate (Ritalin) but carry a rare (~1 in 500) risk of amphetamine-induced psychosis that can persist for months or permanently.
- Stimulant medications in childhood actually reduce lifetime addiction risk by roughly half, countering the common assumption that they create dependency.
- Cyclic sighing (physiological sigh) for ~5 minutes at bedtime has demonstrated benefits for both sleep onset and sleep maintenance by downregulating the arousal system.
- Social media and smartphone use are training the brain toward ADHD-like attention patterns in the general population, though this differs from clinical ADHD.
- ADHD reduces life expectancy by ~10 years, primarily through accidents and impulsivity-driven suicide risk—a consequence as significant as diabetes or major depression.
Detailed Notes
What ADHD Actually Is
- Diagnosed via 18 symptoms: 9 inattentive (forgetting tasks, losing items, distractibility) and 9 hyperactive-impulsive (interrupting, fidgeting, blurting).
- Adults need at least 5 symptoms that appear across multiple life domains and cause measurable dysfunction or distress.
- Until the mid-1990s, ADHD was believed to be outgrown in childhood—this is now known to be false; most adults fluctuate in symptom severity over time.
- ADHD is better understood as a problem with executive function: working memory, selective attention, emotional regulation, and impulse control.
- The ADHD brain is less able to self-impose structure, making it more reliant on optimal external structure.
The Interest-Driven vs. Importance-Driven Brain
- Non-ADHD brains are importance-driven: they do what needs to be done.
- ADHD brains are interest-driven: engagement depends heavily on novelty, challenge, and personal relevance.
- This has career implications: many people with ADHD thrive not in a single 50-year career but in multiple sequential careers across different fields.
Structure and Environment
- ADHD thrives with optimal structure—not too rigid (e.g., assembly line work), not too loose (e.g., unstructured remote work).
- COVID-19 simultaneously reduced structure (no office norms, commutes, social anchors) and increased cognitive demands, creating a “perfect storm” for worsening ADHD—evidenced by a dramatic rise in diagnoses and stimulant prescriptions.
Hyperfocus and Flow
- Hyperfocus is a recognized ADHD phenomenon where attention becomes intensely locked onto an interesting, appropriately challenging task.
- Dr. Kruse considers hyperfocus to be essentially the same as flow state (as described by Csikszentmihalyi): loss of time awareness, spatial immersion, task engagement at the edge of ability.
- The challenge in ADHD: hyperfocus appears at unwanted times and may be hard to summon voluntarily.
ADHD and Lifespan / Risk
- ADHD is associated with a ~10-year reduction in life expectancy, comparable to diabetes or major depression.
- Primary causes: accidents (including motor vehicle) and suicide (driven largely by impulsivity, not just despair).
- ADHD is linked to ~40% lifetime substance use disorder risk, nearly double the general population rate of ~20%.
The Four Behavioral Foundations
Before medication, Dr. Kruse recommends establishing:
- Sleep — especially consistent sleep timing, not just duration. Being a night owl is often biologically driven in ADHD; consistency matters more than conforming to conventional schedules.
- Regular meals — people with ADHD frequently forget to eat or fragment meals. A set schedule is protective; skipping meals is a real-world diagnostic signal.
- Exercise/movement — acute aerobic exercise improves executive function measurably; chronic exercise improves sustained attention. Avoid vigorous exercise too late in the day.
- Relaxation/me-time — includes meditation, downtime, and techniques like cyclic sighing.
Sleep: Timing, Arousal, and Cyclic Sighing
- The timing of sleep is as important as duration—a fact supported by decades of circadian rhythm research but rarely included in public health messaging.
- Most insomnia is not caused by a weak sleep system—it’s caused by a failure of the daytime arousal system to disengage. Sleep is present and waiting; arousal blocks it.
- Practical tools for sleep:
- No phone in the bedroom (having it present—even off—increases mental arousal).
- Consistent bedtime supported by a partner or household member (framed as collaborative, not nagging).
- Cyclic sighing: ~5 minutes, ~20–25 breath cycles, counted (not timed) to avoid re-arousing. Focus on longer exhale than inhale. Dr. Kruse reports it improved both sleep onset and mid-night waking frequency.
- Stimulant medications can paradoxically improve sleep in ADHD patients by providing daytime structure and reducing the end-of-day energy crash.
Medication Overview
Amphetamine-Based (Adderall, Vyvanse)
- Mechanism: strong dopamine and norepinephrine reuptake blocker + vesicular releaser (forces larger synaptic release).
- Most efficacious class for ADHD symptom reduction.
- Key risk: amphetamine-induced psychosis
- Occurs in ~1 in 500 people at therapeutic doses.
- Presents as paranoid delusions (not euphoria); distinct from mania.
- Can persist for weeks to months after stopping medication; ~20% remain in a permanent psychotic state at 20-year follow-up.
- Higher risk in individuals with prior brain vulnerability (e.g., HIV, prior methamphetamine use, prior psychotic episodes).
- Dr. Kruse notes this risk is rarely disclosed to patients by prescribers.
Methylphenidate (Ritalin and extended-release forms)
- Mechanism: primarily a dopamine and norepinephrine reuptake inhibitor with weak or absent vesicular release effects.
- Functionally closer to Wellbutrin than to amphetamine in mechanism.
- Efficacy places it above non-stimulants but below amphetamines when data are examined separately.
Non-Stimulants (Wellbutrin, Strattera/atomoxetine, Intuniv/guanfacine, Qelbree/viloxazine)
- Lower overall efficacy than stimulants for ADHD symptoms.
- Wellbutrin acts as a dopamine and norepinephrine reuptake inhibitor; can improve sleep architecture (especially REM) as a side effect.
- Useful for patients with psychosis risk, substance use history, or preference to avoid stimulants.
Modafinil
- Mentioned as